نمایش پرونده ساده آیتم

dc.contributor.authorSohrabi, N
dc.contributor.authorValizadeh, A
dc.contributor.authorFarkhani, SM
dc.contributor.authorAkbarzadeh, A
dc.date.accessioned2018-08-26T07:30:39Z
dc.date.available2018-08-26T07:30:39Z
dc.date.issued2016
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/47160
dc.description.abstractThe human genome is exposed to mutations during the life cycle because of many types of changes in the DNA. Viruses, radiation, transposons, mutagenic chemicals, or any errors that happen during DNA replication or the meiotic process in the cell, may cause the mutation. Many mutations have no effect on phenotype or health, while some mutations cause crucial diseases such as cancer or cardiac diseases; therefore, a better understanding of the effects of mutation on phenotype is a very important part of genetic studies. Biosensors based on DNA, RNA, and peptide nucleic acids are the most sensitive tools, due to a strong pairing of lined up nucleotide strands between bases in their complementary parts. These methods can provide information to assist clinicians in making successful treatment decisions and increase the patient survival rate. In this review, we discuss DNA biosensors based on peptide nucleic acids that have an important role in cancer diagnosis.
dc.language.isoEnglish
dc.relation.ispartofARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
dc.subjectgene mutation
dc.subjectDNA
dc.subjectcancer
dc.subjectpeptide nucleic acids
dc.subjectDNA biosensor
dc.titleBasics of DNA biosensors and cancer diagnosis
dc.typeArticle
dc.citation.volume44
dc.citation.issue2
dc.citation.spage654
dc.citation.epage663
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.3109/21691401.2014.976707


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم